Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs

Abstract Background Safety of sulfonylurea drugs in the treatment of Type 2 Diabetes is still under debate. The aim of this study was to compare the all-cause mortality and cardiovascular adverse events of sulfonylureas and drugs with a low risk for hypoglycaemia in adults with type 2 diabetes. Meth...

Full description

Bibliographic Details
Main Authors: Vallo Volke, Urmeli Katus, Annika Johannson, Karolin Toompere, Keiu Heinla, Kertu Rünkorg, Anneli Uusküla
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Endocrine Disorders
Subjects:
Diabetes mellitus
Hypoglycemic therapy
Sulfonylurea
All-cause mortality
MACE
Online Access:https://doi.org/10.1186/s12902-022-01158-5

Internet

https://doi.org/10.1186/s12902-022-01158-5

Similar Items